Literature DB >> 34970796

Brainstem Biomarkers of Clinical Variant and Pathology in Progressive Supranuclear Palsy.

Rosalie M Grijalva1, Nha Trang Thu Pham1, Qiao Huang1, Peter R Martin2, Farwa Ali3, Heather M Clark3, Joseph R Duffy3, Rene L Utianski3, Hugo Botha3, Mary M Machulda4, Stephen D Weigand2, J Eric Ahlskog3, Dennis W Dickson5, Keith A Josephs3, Jennifer L Whitwell1.   

Abstract

BACKGROUND: Magnetic resonance brainstem measurements are useful structural biomarkers in the Richardson's syndrome variant of progressive supranuclear palsy (PSP). However, it is unclear how these biomarkers differ across the phenotypic spectrum of PSP and how they relate to underlying pathology.
OBJECTIVE: The aim of this study was to compare brainstem imaging measures across clinical variants of PSP and determine sensitivity and specificity based on pathologically diagnosed cases.
METHODS: A total of 153 patients with PSP who represented eight clinical variants were recruited at Mayo Clinic (Rochester, MN, USA) and underwent structural magnetic resonance imaging (MRI). Midbrain and pons area and superior and middle cerebellar peduncle width measurements were performed, and midbrain/pons ratio and Magnetic Resonance Parkinsonism Index (MRPI) were calculated. Among the 43 patients who later died, PSP pathology was confirmed in 29, whereas 14 had other pathology.
RESULTS: Brainstem measurements varied across PSP clinical variants and were most abnormal in PSP-Richardson's syndrome and frontal variants, followed by PSP-corticobasal, PSP-speech/language, and PSP-parkinsonism variants. All these variants showed abnormalities compared with controls. The PSP-gait freezing variant and patients with prominent corticospinal tract signs showed normal brainstem measures. Among cases with confirmed PSP pathology, the midbrain area, midbrain/pons ratio, and MRPI were all more abnormal compared to those with other pathologies, with best differentiation obtained with the MRPI (sensitivity = 83%; specificity = 85%).
CONCLUSIONS: MRI brainstem measures show utility as diagnostic biomarkers across PSP clinical variants and have the potential to be useful in predicting underlying pathology.
© 2021 International Parkinson and Movement Disorder Society. © 2021 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  MRI; MRPI; PSP-P; PSP-RS; autopsy

Mesh:

Substances:

Year:  2021        PMID: 34970796      PMCID: PMC9018485          DOI: 10.1002/mds.28901

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   9.698


  61 in total

1.  The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment.

Authors:  Ziad S Nasreddine; Natalie A Phillips; Valérie Bédirian; Simon Charbonneau; Victor Whitehead; Isabelle Collin; Jeffrey L Cummings; Howard Chertkow
Journal:  J Am Geriatr Soc       Date:  2005-04       Impact factor: 5.562

Review 2.  Neuropathology of variants of progressive supranuclear palsy.

Authors:  Dennis W Dickson; Zeshan Ahmed; Avi A Algom; Yoshio Tsuboi; Keith A Josephs
Journal:  Curr Opin Neurol       Date:  2010-08       Impact factor: 5.710

3.  New and reliable MRI diagnosis for progressive supranuclear palsy.

Authors:  H Oba; A Yagishita; H Terada; A J Barkovich; K Kutomi; T Yamauchi; S Furui; T Shimizu; M Uchigata; K Matsumura; M Sonoo; M Sakai; K Takada; A Harasawa; K Takeshita; H Kohtake; H Tanaka; S Suzuki
Journal:  Neurology       Date:  2005-06-28       Impact factor: 9.910

4.  Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech.

Authors:  Keith A Josephs; Joseph R Duffy; Edyth A Strand; Jennifer L Whitwell; Kenneth F Layton; Joseph E Parisi; Mary F Hauser; Robert J Witte; Bradley F Boeve; David S Knopman; Dennis W Dickson; Clifford R Jack; Ronald C Petersen
Journal:  Brain       Date:  2006-04-13       Impact factor: 13.501

5.  MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy.

Authors:  Aldo Quattrone; Giuseppe Nicoletti; Demetrio Messina; Francesco Fera; Francesca Condino; Pierfrancesco Pugliese; Pierluigi Lanza; Paolo Barone; Letterio Morgante; Mario Zappia; Umberto Aguglia; Olivier Gallo
Journal:  Radiology       Date:  2007-11-08       Impact factor: 11.105

6.  The clinical spectrum and natural history of pure akinesia with gait freezing.

Authors:  Emily Owens; Keith A Josephs; Rodolfo Savica; Anhar Hassan; Bryan Klassen; James Bower; Demetrius Maraganore; Joseph Matsumoto; J E Ahlskog
Journal:  J Neurol       Date:  2016-09-13       Impact factor: 4.849

7.  Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism.

Authors:  David R Williams; Rohan de Silva; Dominic C Paviour; Alan Pittman; Hilary C Watt; Linda Kilford; Janice L Holton; Tamas Revesz; Andrew J Lees
Journal:  Brain       Date:  2005-03-23       Impact factor: 13.501

8.  Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan.

Authors:  Christopher G Goetz; Stanley Fahn; Pablo Martinez-Martin; Werner Poewe; Cristina Sampaio; Glenn T Stebbins; Matthew B Stern; Barbara C Tilley; Richard Dodel; Bruno Dubois; Robert Holloway; Joseph Jankovic; Jaime Kulisevsky; Anthony E Lang; Andrew Lees; Sue Leurgans; Peter A LeWitt; David Nyenhuis; C Warren Olanow; Olivier Rascol; Anette Schrag; Jeanne A Teresi; Jacobus J Van Hilten; Nancy LaPelle
Journal:  Mov Disord       Date:  2007-01       Impact factor: 10.338

9.  Accuracy of MR markers for differentiating Progressive Supranuclear Palsy from Parkinson's disease.

Authors:  Stefano Zanigni; Giovanna Calandra-Buonaura; David Neil Manners; Claudia Testa; Dino Gibertoni; Stefania Evangelisti; Luisa Sambati; Maria Guarino; Patrizia De Massis; Laura Ludovica Gramegna; Claudio Bianchini; Paola Rucci; Pietro Cortelli; Raffaele Lodi; Caterina Tonon
Journal:  Neuroimage Clin       Date:  2016-05-30       Impact factor: 4.881

10.  Diagnosis Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Syndrome.

Authors:  Edwin Jabbari; Negin Holland; Viorica Chelban; P Simon Jones; Ruth Lamb; Charlotte Rawlinson; Tong Guo; Alyssa A Costantini; Manuela M X Tan; Amanda J Heslegrave; Federico Roncaroli; Johannes C Klein; Olaf Ansorge; Kieren S J Allinson; Zane Jaunmuktane; Janice L Holton; Tamas Revesz; Thomas T Warner; Andrew J Lees; Henrik Zetterberg; Lucy L Russell; Martina Bocchetta; Jonathan D Rohrer; Nigel M Williams; Donald G Grosset; David J Burn; Nicola Pavese; Alexander Gerhard; Christopher Kobylecki; P Nigel Leigh; Alistair Church; Michele T M Hu; John Woodside; Henry Houlden; James B Rowe; Huw R Morris
Journal:  JAMA Neurol       Date:  2020-03-01       Impact factor: 18.302

View more
  4 in total

1.  Diagnostic Accuracy of Magnetic Resonance Imaging Measures of Brain Atrophy Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Degeneration.

Authors:  Ignacio Illán-Gala; Salvatore Nigro; Lawren VandeVrede; Neus Falgàs; Hilary W Heuer; Cèlia Painous; Yaroslau Compta; Maria J Martí; Victor Montal; Javier Pagonabarraga; Jaime Kulisevsky; Alberto Lleó; Juan Fortea; Giancarlo Logroscino; Andrea Quattrone; Aldo Quattrone; David C Perry; Maria Luisa Gorno-Tempini; Howard J Rosen; Lea T Grinberg; Salvatore Spina; Renaud La Joie; Gil D Rabinovici; Bruce L Miller; Julio C Rojas; William W Seeley; Adam L Boxer
Journal:  JAMA Netw Open       Date:  2022-04-01

Review 2.  Magnetic Resonance Planimetry in the Differential Diagnosis between Parkinson's Disease and Progressive Supranuclear Palsy.

Authors:  Andrea Quattrone; Maurizio Morelli; Maria G Bianco; Jolanda Buonocore; Alessia Sarica; Maria Eugenia Caligiuri; Federica Aracri; Camilla Calomino; Marida De Maria; Maria Grazia Vaccaro; Vera Gramigna; Antonio Augimeri; Basilio Vescio; Aldo Quattrone
Journal:  Brain Sci       Date:  2022-07-20

Review 3.  Clinical Spectrum of Tauopathies.

Authors:  Nahid Olfati; Ali Shoeibi; Irene Litvan
Journal:  Front Neurol       Date:  2022-07-14       Impact factor: 4.086

4.  Morphometric imaging and quantitative susceptibility mapping as complementary tools in the diagnosis of parkinsonisms.

Authors:  Sonia Mazzucchi; Eleonora Del Prete; Mauro Costagli; Daniela Frosini; Davide Paoli; Gianmichele Migaleddu; Paolo Cecchi; Graziella Donatelli; Riccardo Morganti; Gabriele Siciliano; Mirco Cosottini; Roberto Ceravolo
Journal:  Eur J Neurol       Date:  2022-06-27       Impact factor: 6.288

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.